Drug Manufacturers - Specialty & Generic · Healthcare
CFO
Equibles does not estimate personal net worth.
Get an email with a short summary when Green Thumb Industries Inc. publishes a filing, an earnings call transcript or a press release.
Get GTBIF alertsMatt Faulkner is recorded as CFO at Green Thumb Industries Inc. (GTBIF). The proxy statement of Green Thumb Industries Inc. reports total compensation of $1,758,432 for Matt Faulkner in fiscal 2025, including a base salary of $335,721. Disclosed compensation is on record for 3 fiscal years. Matt Faulkner has spoken on 4 earnings calls across 1 company, most recently for Green Thumb Industries Inc. on August 4, 2026. Green Thumb Industries Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Green Thumb Industries Inc. includes Benjamin Kovler (CEO and Board Member), Mathew Faulkner (CFO and Chief Accounting Officer), Bret Kravitz (General Counsel) and 7 others.
“Increased 5% year over year, driven in large part due to adult use sales launch in Minnesota, along with net CPG growth and new store contributions. Pricing pressures continue to weigh in the top line, even as we see sales.”
“In the second quarter, we delivered over $293 million in revenue, a 5% increase compared to Revenue was driven by increased consumer packaged goods sales. overall retail revenue was up slightly versus the second quarter of 2024 due to new stores offset by significant pricing pressure second quarter 2025 comfortable…”
“In the first quarter, we delivered $280 million in revenue, a 1% increase compared to increased consumer packaged goods sales. Overall, retail revenue declined 3% versus the first quarter of 2024 due to significant pricing.”
“In the fourth quarter, we delivered over $294 million in revenue, a six percent increase compared to the prior year period revenue is primarily driven by overall retail revenue increased one percent reflecting continued growth in existing markets of new york florida and maryland the addition of adult use sales in ohio…”
Drug Manufacturers - Specialty & Generic · Healthcare
CFO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Green Thumb Industries Inc. (GTBIF) | Chief Financial Officer | $335,721 | $1,758,432 |
| 2024 | Green Thumb Industries Inc. (GTBIF) | Chief Financial Officer | $345,013 | $4,599,979 |
| 2023 | Green Thumb Industries Inc. (GTBIF) | Chief Financial Officer | $345,013 | $1,733,187 |